Protein to biomaterials: Unraveling the antiviral and proangiogenic activities of Ac-Tβ1-17 peptide, a thymosin β4 metabolite, and its implications in peptide-scaffold preparation
Open Access
- 1 July 2025
- journal article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 49, 437-455
Abstract
Peptide metabolites are emerging biomolecules with numerous possibilities in biomaterial-based regenerative medicine due to their inherent bioactivities. These small, naturally occurring compounds are intermediates or byproducts of larger proteins and peptides, and they can have profound effects, such as antiviral therapeutics, proangiogenic agents, and regenerative medicinal applications. This study is among the first to focus on using thymosin β4 protein-derived metabolites to pioneer novel applications for peptide metabolites in biomaterials. This study found that the novel peptide metabolite acetyl-thymosin β4 (amino acid 1–17) (Ac-Tβ1-17) exhibited significant protease inhibition activity against SARS-CoV-2, surpassing its precursor protein. Additionally, Ac-Tβ1-17 demonstrated beneficial effects, such as cell proliferation, wound healing, and scavenging of reactive oxygen species (ROS) in human umbilical vein endothelial cells (HUVEC). Integrating Ac-Tβ1-17 into a peptide-based scaffold facilitated cell growth and angiogenesis inside the scaffold and through gradual release into the surrounding environment. The Ac-Tβ1-17 peptide treatment induced significant biochemical responses in HUVEC, increasing Akt, ERK, PI3K, MEK, and Bcl-2 gene expression and proangiogenic proteins. Ac-Tβ1-17 peptide treatment showed similar results in ex vivo by enhancing mouse fetal metatarsal growth and angiogenesis. These findings highlight the potential of natural protein metabolites to generate biologically active peptides, offering a novel strategy for enhancing biomaterial compatibility. This approach holds promise for developing therapeutic biomaterials using peptide metabolites, presenting exciting prospects for future research and applications.Keywords
Funding Information
- Korea Institute of Science and Technology (2Z07012)
- Korea Institute of Science and Technology (2E33311)
- KU-KIST Graduate School of Converging Science and Technology
- Gyeongnam National University of Science and Technology
- National Research Foundation of Korea (NRF-2021R1A2C2092375)
- National Research Foundation of Korea (NRF-2022M3H4A1A0407327112)
- National Research Foundation of Korea (NRF-2021K1A3A1A74095929)
This publication has 66 references indexed in Scilit:
- Annual banned‐substance review 16th edition—Analytical approaches in human sports drug testing 2022/2023Drug Testing and Analysis, 2023
- Detection and quantification of the metabolite Ac‐Tβ1–14 in in vitro experiments and urine of rats treated with Ac‐Tβ4: A potential biomarker of Ac‐Tβ4 for doping testsDrug Testing and Analysis, 2023
- The use of peptides, aptamers, and variable domains of heavy chain only antibodies in tissue engineering and regenerative medicineActa Biomaterialia, 2023
- An approach for identifying in silico peptides against authentic metabolites: in vitro characterization of thymosin β4 metabolitesJournal of Pharmaceutical Investigation, 2022
- Peptide-Based Vaccines and Therapeutics for COVID-19International Journal of Peptide Research and Therapeutics, 2022
- Angiogenic biomaterials to promote therapeutic regeneration and investigate disease progressionBiomaterials, 2020
- Biodegradable Magnesium Alloys Promote Angio‐Osteogenesis to Enhance Bone RepairAdvanced Science, 2020
- Antiinflammatory peptides: current knowledge and promising prospectsInflammation Research, 2018
- Pro-angiogenic peptides in biomedicineArchives of Biochemistry and Biophysics, 2018
- Evolving the use of peptides as components of biomaterialsBiomaterials, 2011